Abstract: A contactless checkout system with theft detection, and related methods and devices. An inventory of an electronic shopping cart of a user in a retail environment and a virtual inventory of a physical shopping container in possession of the user in the retail environment are maintained. Actions performed by the user, such as placing or removing an item from the physical shopping container, are detected using computer vision. An item associated with each detected action is determined using computer vision based on an inventory storage location at which the detected action occurred. The virtual inventory of the physical shopping container is updated based on detected actions and the associated items. An alert is generated in response to a determination that the virtual inventory of the physical shopping container does not match the inventory of the electronic shopping cart.

Abstract: The invention concerns new peptidomimetic (or peptoid) molecules for the prevention and/or treatment of chronic pain, particularly that resulting from peripheral neuropathies.

Abstract: The present invention relates to a composition comprising a pharmaceutically acceptable carrier, at least one compound of the avermectin family, and at least one non-steroidal anti-inflammatory compound. The present invention further provides such composition for use in the treatment and/or the prevention of rosacea.

Abstract: A method and device are provided for determining a mode of detection of an element that reflects ultrasonic waves, wherein it comprises at least the following steps: For each point P of a given volume Zr, determining an ultrasonic field value Aijm (P) for N emitter-receiver pairs (i, j) and for one detection mode m, computing a number C m ? ( P , n ? ) = ? i , j = 1 N ? ? c ij m ? ( P , n ? ) of reflections of the wave where c ij m = { 1 if ? ? ? n ? ij m ? ( P ) · n ? ? = 1 0 if ? ? not with {right arrow over (n)}ijm(P) the normal formed by the “forward” direction {right arrow over (d)}i and the “backward” direction {right arrow over (d)}j of the ultrasonic wave emitted and reflected by the reflecting element, computing the energy value Em(P,{right arrow over (n)}) for each point P of the zone Zr, with {right arrow over (n)} and for a plurality of modes m with E m ? ( P , n ? ) = ? i , j = 1

Abstract: A method for manufacturing a dental restoration pre-form for use in a making a dental prosthesis is disclosed comprising providing a design of the prosthesis and a protocol for manufacturing the prosthesis and producing a dental restoration material pre-form having three dimensional (3D) characteristics based on said design of the prosthesis and steps of the protocol. There is also disclosed a method for manufacturing a dental prosthesis comprising providing dental restoration material pre-form having an associated 3D digital map, the 3D map comprising information on a spatial distribution of characteristics of the pre-form; and processing the pre-form according to a processing protocol the protocol based on a design of the prosthesis and the 3D map of the pre-form.

Abstract: A system and method for optimising the preparation of dental restorations is provided. The system comprises a dental restoration surface processing unit, a dental restoration assessment unit, a database comprising a treatment parameters database and a processing protocols database, a processor operationally coupled to said dental restoration surface processing unit and a protocol selector. The method treats a dental restoration surface using the system and according to one or more selected processing protocol.

Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.

Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.

Abstract: Benzenesulfonamide compounds having a structure of the following general formula (I) are described. Also described, are methods for synthesizing the compounds, and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.

Abstract: A combination of compounds for treating skin diseases and particularly rosacea and ocular rosacea is described. The combination of a compound of the avermectin family or of the mylbemycin family with a compound of the family of the alpha-1 or alpha-2 adrenergic receptor agonists is also described. In addition, a product in the form of a kit including: (a) a first composition containing a compound of the avermectin family or of the mylbemycin family, and (b) a second composition different from the first one and containing a compound of the family of the alpha-1 or alpha-2 adrenergic receptor agonists, as a combination product to be used as a drug for treating and/or preventing skin diseases and particularly rosacea and ocular rosacea, wherein said first and second compositions can be applied simultaneously, separately or with a time delay is described.

Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.

Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.

Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.

Abstract: Benzenesulfonamide compounds having a structure of the following general formula (I) are described. Also described, are methods for synthesizing the compounds, and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.

Abstract: A combination of compounds for treating skin diseases and particularly rosacea and ocular rosacea is described. The combination of a compound of the avermectin family or of the mylbemycin family with a compound of the family of the alpha-1 or alpha-2 adrenergic receptor agonists is also described. In addition, a product in the form of a kit including: (a) a first composition containing a compound of the avermectin family or of the mylbemycin family, and (b) a second composition different from the first one and containing a compound of the family of the alpha-1 or alpha-2 adrenergic receptor agonists, as a combination product to be used as a drug for treating and/or preventing skin diseases and particularly rosacea and ocular rosacea, wherein said first and second compositions can be applied simultaneously, separately or with a time delay is described.

Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radical of formulae (a) to (c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively, into cosmetic compositions.

Abstract: The aim of the invention is to provide inter-channel level differences ICLD related to audio signals for hearing aids.

Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radical of formulae (a) to (c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively, into cosmetic compositions.

Abstract: Topically applicable pharmaceutical gel, cream, lotion, solution or ointment compositions contain synergistically effective amounts of a) calcitriol and b) clobetasol propionate, formulated into a topically applicable, pharmaceutically acceptable medium therefor, and are useful for the treatment of such dermatological afflictions or conditions as psoriasis, atopic dermatitis, contact dermatitis and seborrhoeic dermatitis.